Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nambu

Showing results (1111-1120 of 1,149) with videos related to

Pageof 115
Sort By:
Communications Physics|June 25, 2024
Deformation of the moving magnetic skyrmion lattice in MnSi under electric current flowD Okuyama, M Bleuel, J S White, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Molecular Cancer Therapeutics|November 6, 2009
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agentsHiroshi Hirai, Yoshikazu Iwasawa, Megumu Okada, et al.
Cardiovascular Research|May 14, 2020
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intoleranceHideo Nambu, Shingo Takada, Satoshi Maekawa, et al.
Intestinal Research|February 24, 2026
Characteristics of monogenic inflammatory bowel disease in very early-onset cases: a Japanese multicenter registry studyNatsuki Ito, Takahiro Kudo, Keisuke Jimbo, et al.
Nature Structural & Molecular Biology|September 20, 2024
Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growthYing Zhang, Kaijing Chen, Seng Chuan Tang, et al.
Scientific Reports|March 16, 2021
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel diseaseLuca Bosa, Vritika Batura, Davide Colavito, et al.
Scientific Reports|December 22, 2018
IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammationYoshihisa Hiraishi, Sachiko Yamaguchi, Takamichi Yoshizaki, et al.
Science Advances|May 28, 2019
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitorKenichi Iwai, Tadahiro Nambu, Ryo Dairiki, et al.
Journal of Medicinal Chemistry|August 29, 2012
Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancerJ Jean Cui, Michele McTigue, Mitchell Nambu, et al.
Pageof 115

Showing results (1111-1120 of 1,149) with videos related to

Sort By:
Pageof 115
Communications Physics|June 25, 2024
Deformation of the moving magnetic skyrmion lattice in MnSi under electric current flowD Okuyama, M Bleuel, J S White, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Molecular Cancer Therapeutics|November 6, 2009
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agentsHiroshi Hirai, Yoshikazu Iwasawa, Megumu Okada, et al.
Cardiovascular Research|May 14, 2020
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intoleranceHideo Nambu, Shingo Takada, Satoshi Maekawa, et al.
Intestinal Research|February 24, 2026
Characteristics of monogenic inflammatory bowel disease in very early-onset cases: a Japanese multicenter registry studyNatsuki Ito, Takahiro Kudo, Keisuke Jimbo, et al.
Nature Structural & Molecular Biology|September 20, 2024
Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growthYing Zhang, Kaijing Chen, Seng Chuan Tang, et al.
Scientific Reports|March 16, 2021
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel diseaseLuca Bosa, Vritika Batura, Davide Colavito, et al.
Scientific Reports|December 22, 2018
IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammationYoshihisa Hiraishi, Sachiko Yamaguchi, Takamichi Yoshizaki, et al.
Science Advances|May 28, 2019
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitorKenichi Iwai, Tadahiro Nambu, Ryo Dairiki, et al.
Journal of Medicinal Chemistry|August 29, 2012
Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancerJ Jean Cui, Michele McTigue, Mitchell Nambu, et al.
Pageof 115